Dyslipidaemias are alterations to the plasma lipid profile that are often associated with
clinical conditions. Dyslipidaemias, particularly elevated plasma LDL-cholesterol levels, are …

Aims To report the prevalence, deaths, and disability-adjusted life years (DALYs) associated
with ischemic heart disease (IHD) and its attributable risk factors in 204 countries and …

Abstract Purpose of Review The Middle East and North Africa has witnessed a dramatic
transformation over the last 30 years caused by rapid urbanization and modernization and …

Objective: The present study was designed to identify potential diagnostic markers for acute
myocardial infarction (AMI) and determine the significance of immune cell infiltration in this …

Background: Accurate information on stroke burden in men and women are important for
evidence-based healthcare planning and resource allocation. Previously, limited research …

Background Increased urbanization in the developing world parallels a rising burden of
chronic diseases. Developing countries account for∼ 80% of global cardiovascular (CV) …

Cardiovascular disease (CVD) is reported to be the leading cause of mortality in the middle
eastern countries, including Qatar. But no comprehensive study has been conducted on the …

Background and aims Disorders of plasma lipids remain key risk factors for the development
of atherosclerotic cardiovascular disease (ASCVD) in the Middle East and are estimated to …

The increase in the cardiovascular disease (CVD)-associated mortality rate in the Middle
East (ME) is among the highest in the world. The aim of this article is to review the current …

Background: Cardiovascular disease is the first leading cause of death worldwide. Coronary
heart disease is the most common manifestation of cardiovascular disease. Acute …